Results 161 to 170 of about 16,213 (201)

Integrating Next Generation sequencing into the risk assessment of primary myelofibrosis. [PDF]

open access: yesHematol Transfus Cell Ther
Reis-Vieira R   +10 more
europepmc   +1 more source

Molecular and Serological Evidence of Oropouche Virus Circulation in Asymptomatic Blood Donors During the 2023-2024 Outbreak in Manaus, Brazil. [PDF]

open access: yesJ Infect Dis
Milani P   +14 more
europepmc   +1 more source

Sociodemographic, Clinical, and Therapeutic Characterization of Multiple Myeloma Patients (CharisMMa Study) with Symptomatic Relapse and/or Refractory Disease: An Observational, Multicenter Study in Portugal. [PDF]

open access: yesHematol Rep
Bergantim R   +12 more
europepmc   +1 more source

Melatonin potentiates the antineoplastic effects of venetoclax in acute myeloid leukemia cells. [PDF]

open access: yesHematol Transfus Cell Ther
Vahedian V   +5 more
europepmc   +1 more source

Niveles de anticuerpos naturales antibanda 3 y de hemoglobina en enfermos con leucemia mieloide crónica

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia
Rinaldo Villaescusa Blanco   +6 more
doaj  

Prevalence of parvovirus B19 infection in patients with hematological diseases in the Western Brazilian Amazon. [PDF]

open access: yesHematol Transfus Cell Ther
de Souza PHR   +8 more
europepmc   +1 more source

Estudio seriado de anticuerpos naturales antibanda 3 en enfermos con drepanocitosis

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia
Ada Amalia Arce Hernández   +6 more
doaj  

Ultrasonido doppler transcraneal en la prevención del accidente vascular encefálico en niños con drepanocitosis

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia
Andrea Menéndez Veitía   +10 more
doaj  

Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting. [PDF]

open access: yesHematol Transfus Cell Ther
Gutierrez-Aguirre CH   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy